The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion: 1-Year Results From the Phase 3 COPERNICUS Study
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Martin, D. F., Maguire, M. G., Fine, S. L., Ying, G.-S., Jaffe, G. J., Grunwald, J. E., Toth, C., Redford, M., & Ferris, F. L. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.03.053 · Cited by 1,715
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691 · cited 2×
“Intravitreal aflibercept injection, also known as VEGF Trap-Eye (Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA) is a 115-kDa decoy receptor fusion protein, composed of the second domain of human VEGF receptor 1 and the third domain of VEGF receptor 2 fused to the Fc domain of human IgG1.(8,9) The binding aff…”
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
Brown, D. M., Campochiaro, P. A., Singh, R. P., Li, Z., Gray, S., Saroj, N., Rundle, A. C., Rubio, R. G., & Murahashi, W. Y. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.022 · Cited by 1,155
Self-citationPapadopoulos, N., Martin, J., Ruan, Q., Rafique, A., Rosconi, M. P., Shi, E., Pyles, E. A., Yancopoulos, G. D., Stahl, N., & Wiegand, S. J. (2012) · Angiogenesis · doi:10.1007/s10456-011-9249-6 · Cited by 1,037
Photocoagulation for Diabetic Macular Edema
Aiello, L. M., & Ferris, F. L. (1987) · Archives of Ophthalmology · doi:10.1001/archopht.1987.01060090021004 · Cited by 733
Campochiaro, P. A., Brown, D. M., Awh, C. C., Lee, S. Y., Gray, S., Saroj, N., Murahashi, W. Y., & Rubio, R. G. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.038 · Cited by 711
Self-citationEvaluation of Grid Pattern Photocoagulation for Macular Edema in Central Vein Occlusion
Clarkson, J. G., Chuang, E., Gass, D., Pedroso, M., Cubillas, T., Duria, E. S., Hess, D. J., Rams, I., Ball, M., Gutierrez, A., et al. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30849-4 · Cited by 508
Ranibizumab for Macular Edema Due to Retinal Vein Occlusions
Heier, J. S., Campochiaro, P. A., Yau, L., Li, Z., Saroj, N., Rubio, R. G., & Lai, P. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.12.005 · Cited by 470
Self-citationOne-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema
Do, D. V., Nguyen, Q. D., Boyer, D., Schmidt-Erfurth, U., Brown, D. M., Vitti, R., Berliner, A. J., Gao, B., Zeitz, O., Ruckert, R., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.02.010 · Cited by 385
Self-citationPredicted biological activity of intravitreal VEGF Trap
Stewart, M. W., & Rosenfeld, P. J. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.134874 · Cited by 375
Cytokine traps: multi-component, high-affinity blockers of cytokine action
Economides, A. N., Carpenter, L. R., Rudge, J. S., Wong, V., Koehler-Stec, E. M., Hartnett, C., Pyles, E. A., Xu, X., Daly, T. J., Young, M. R., et al. (2003) · Nature Medicine · doi:10.1038/nm811 · Cited by 359
Campochiaro, P. A., Hafiz, G., Shah, S. M., Nguyen, Q. D., Ying, H., Do, D. V., Quinlan, E., Zimmer-Galler, I., Haller, J. A., Solomon, S. D., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.10 · Cited by 321
Self-citationBoyer, D., Heier, J., Brown, D. M., Clark, W. L., Vitti, R., Berliner, A. J., Groetzbach, G., Zeitz, O., Sandbrink, R., Zhu, X., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.01.042 · Cited by 258
Self-citation
Cited by
Ten years of anti-vascular endothelial growth factor therapy
Ferrara, N., & Adamis, A. P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.17 · Cited by 1,030
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion
Campochiaro, P. A., Clark, W. L., Boyer, D. S., Heier, J. S., Brown, D. M., Vitti, R., Kazmi, H., Berliner, A. J., Erickson, K., Chu, K. W., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2014.08.031 · Cited by 385
Self-citationLong-term Outcomes in Patients with Retinal Vein Occlusion Treated with Ranibizumab
Campochiaro, P. A., Sophie, R., Pearlman, J., Brown, D. M., Boyer, D. S., Heier, J. S., Marcus, D. M., Feiner, L., & Patel, A. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.08.038 · Cited by 351
Self-citationSchmidt-Erfurth, U., Garcia-Arumi, J., Gerendas, B. S., Midena, E., Sivaprasad, S., Tadayoni, R., Wolf, S., & Loewenstein, A. (2019) · Ophthalmologica · doi:10.1159/000502041 · Cited by 284
Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion
Korobelnik, J.-F., Holz, F. G., Roider, J., Ogura, Y., Simader, C., Schmidt-Erfurth, U., Lorenz, K., Honda, M., Vitti, R., Berliner, A. J., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.08.012 · Cited by 284
Self-citation
Metadata
- Authors
- Brown, D. M., Heier, J. S., Clark, W. L., Boyer, D. S., Vitti, R., Berliner, A. J., Zeitz, O., Sandbrink, R., Zhu, X., & Haller, J. A.
- Venue
- American Journal of Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 155
- Issue
- 3
- Pages
- 429-437.e7
- ISSN
- 0002-9394 (ISSN-L)
- OpenAlex
- W2172223254
- Cited by
- 365
- References
- 14
- FWCI
- 25.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.